# OnCo record richard-stone (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/richard-stone/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "richard-stone" ;
  schema:name "Richard M. Stone"@en ;
  schema:description "Led RATIFY, the trial that made midostaurin the first targeted therapy added to induction chemotherapy for AML."@en ;
  schema:url <https://onco.cc/people/richard-stone/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Stone%20RM%5BAuthor%5D%20midostaurin%20RATIFY> ;
  onco:tag "aml", "flt3", "cooperative-group" ;
  schema:jobTitle "Chief of Staff and Director of Translational Research, Adult Leukemia Program, Dana-Farber Cancer Institute" ;
  schema:sameAs <https://orcid.org/0000-0002-7526-2633> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:trials <https://onco.cc/trials/ratify/>, <https://onco.cc/trials/quantum-first/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-quantum-first-quizartinib-lancet-2023/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .